Severe ocular side effects with Topamax;Toxicidad oftalmológica severa por Topamax

Archivos de la Sociedad Espanola de Oftalmologia

Volumn 81, Issue 6, 2006, Pages 345-348

  Asensio Sanchez V M ^a   Torreblanca Aguera B ^a   Martinez Calvo S ^a   Calvo, M J ^a   Rodriguez R ^a  

^a HOSPITAL CLÍNICO UNIVERSITARIO DE VALLADOLID   (Spain)

Author keywords

Homonymous hemianopia; Maculopathy; Topiramate

Indexed keywords

ANTICONVULSIVE AGENT; DRUG DERIVATIVE; FRUCTOSE; TOPIRAMATE;

ADOLESCENT; ADULT; ARTICLE; BLINDNESS; CASE REPORT; CHEMICALLY INDUCED DISORDER; FEMALE; HEMIANOPIA; HUMAN; RETINA DISEASE; RETINA MACULA LUTEA; VISUAL FIELD;

ADOLESCENT; ADULT; ANTICONVULSANTS; BLINDNESS; FEMALE; FRUCTOSE; HEMIANOPSIA; HUMANS; MACULA LUTEA; RETINAL DISEASES; VISUAL FIELDS;

EID: 33750125894     PISSN: 03656691     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (5)

1. Fraunfelder FW, Fraunfelder FT. Adverse ocular drug reactions recently identified by the National Registry of Drug-Induced Ocular Side Effects. Ophthalmology 2004; 111: 1275-1279.
2. Thompson PJ, Baxendale SA, Duncan JS, Sander JW. Effects of topiramate on cognitive function. J Neurol Neurosurg Psychiatry 2000; 69: 636-641.
3. Foroozan R, Buono LM. Foggy visual field defect. Surv Ophthalmol 2003; 48: 447-451.
4. Vaphiades MS, Mason J. Foggy visual field defect. Surv Ophthalmol 2004; 49: 266-267.
5. Sills GJ, Butler E, Forrest G, Ratnaraj N, Patsalos PN, Brodie MJ. Vigabatrin, but not gabapentin or topiramate, produces concentration related effects on enzymes and intermediates of the GABA shunt in rat brain and retina. Epilepsia 2003; 44: 886-892.